MUNARI, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 3.077
AS - Asia 2.092
EU - Europa 821
SA - Sud America 693
Continente sconosciuto - Info sul continente non disponibili 99
AF - Africa 51
OC - Oceania 2
Totale 6.835
Nazione #
US - Stati Uniti d'America 2.987
SG - Singapore 810
BR - Brasile 581
CN - Cina 410
HK - Hong Kong 355
VN - Vietnam 210
UA - Ucraina 131
DE - Germania 114
FR - Francia 98
TR - Turchia 89
FI - Finlandia 87
IE - Irlanda 85
RU - Federazione Russa 85
IT - Italia 71
GB - Regno Unito 69
BD - Bangladesh 59
AR - Argentina 50
CA - Canada 34
IN - India 33
ID - Indonesia 25
MX - Messico 19
ZA - Sudafrica 19
IQ - Iraq 17
BE - Belgio 15
CO - Colombia 14
EC - Ecuador 12
PK - Pakistan 12
SA - Arabia Saudita 12
NL - Olanda 11
UZ - Uzbekistan 11
JM - Giamaica 10
JP - Giappone 9
MA - Marocco 9
SE - Svezia 9
VE - Venezuela 9
CL - Cile 8
PL - Polonia 8
CR - Costa Rica 7
AE - Emirati Arabi Uniti 6
AT - Austria 6
PY - Paraguay 6
TN - Tunisia 6
UY - Uruguay 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
NP - Nepal 5
EG - Egitto 4
ES - Italia 4
JO - Giordania 4
LB - Libano 4
MY - Malesia 4
NI - Nicaragua 4
PE - Perù 4
PH - Filippine 4
TT - Trinidad e Tobago 4
AL - Albania 3
CI - Costa d'Avorio 3
DZ - Algeria 3
KE - Kenya 3
RS - Serbia 3
AP - ???statistics.table.value.countryCode.AP??? 2
BB - Barbados 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
IR - Iran 2
LV - Lettonia 2
OM - Oman 2
SN - Senegal 2
SV - El Salvador 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
MT - Malta 1
MU - Mauritius 1
PA - Panama 1
PS - Palestinian Territory 1
PW - Palau 1
SR - Suriname 1
TH - Thailandia 1
Totale 6.738
Città #
Hong Kong 355
Singapore 350
Fairfield 320
The Dalles 251
Ashburn 226
Woodbridge 157
Princeton 140
Seattle 138
San Jose 133
Wilmington 125
Houston 111
Beijing 105
Cambridge 103
Jacksonville 103
Council Bluffs 101
New York 99
Helsinki 83
Istanbul 80
Lauterbourg 80
Dublin 79
Ho Chi Minh City 74
Los Angeles 61
Hanoi 58
Ann Arbor 57
São Paulo 41
Buffalo 38
Redondo Beach 34
San Diego 32
Des Moines 29
Chicago 28
Moscow 28
Dallas 26
Santa Clara 25
Rio de Janeiro 24
Orem 21
Shanghai 21
Chandler 18
London 17
Menlo Park 16
Brussels 15
Columbus 13
Curitiba 13
Brasília 12
Belo Horizonte 11
Dhaka 11
Frankfurt am Main 11
San Francisco 11
Tashkent 11
Munich 10
Atlanta 9
Brooklyn 9
Montreal 9
Nuremberg 9
Romola 9
Amsterdam 8
Boston 8
Buenos Aires 8
Campinas 8
Denver 8
Düsseldorf 8
Elk Grove Village 8
Haiphong 8
Johannesburg 8
Milan 8
Chennai 7
Contagem 7
Da Nang 7
Guayaquil 7
Kingston 7
Paris 7
Salt Lake City 7
Sorocaba 7
Warsaw 7
Manchester 6
Norwalk 6
Phoenix 6
Salvador 6
Tokyo 6
Toronto 6
Brno 5
Chiswick 5
Hải Dương 5
Joinville 5
Manaus 5
Montevideo 5
Poplar 5
Praia Grande 5
Recife 5
San José 5
Stockholm 5
Thái Bình 5
Uberlândia 5
Wandsworth 5
Ankara 4
Boardman 4
Brescia 4
Bắc Giang 4
Cairo 4
Changsha 4
Dubai 4
Totale 4.227
Nome #
Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms 148
Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma 141
Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors 122
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma 121
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 111
Prevalence of PD-L1 expression in head and neck squamous precancerous lesions: a systematic review and meta-analysis 109
Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis 107
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge 105
ALK-positive anaplastic large cell lymphoma with PAX-5 expression: report of a case 105
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 102
Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions 102
An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine 98
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 97
Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma 97
Correction: Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma 94
⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer 94
Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma 93
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 92
ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder 91
PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263 91
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression 91
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 90
Multiplex fluorescence in situ hybridisation to detect anaplastic lymphoma kinase and ROS proto-oncogene 1 receptor tyrosine kinase rearrangements in lung cancer cytological samples 89
Cyclin A1 expression predicts progression in pT1 urothelial carcinoma of bladder: a tissue microarray study of 149 patients treated by transurethral resection 89
NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines 88
“Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy 88
Assessment of HER2 protein overexpression and gene amplification in renal collecting duct carcinoma: Therapeutic implication 86
Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma 85
Human Innate Lymphoid Cells: Their Functional and Cellular Interactions in Decidua 83
Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: a tissue microarray study of 112 cases 82
Artificial intelligence applications for pre-implantation kidney biopsy pathology practice: a systematic review 81
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection 81
Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker 81
Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma 81
PD-L1 expression in non-small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory developed test using clone E1L3N in comparison with 22C3 and SP263 assays 80
High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins 79
Artificial intelligence-based tools applied to pathological diagnosis of microbiological diseases 79
Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: a tissue microarray study of 112 cases 78
PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non-Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs: An Interclone Evaluation by Differently Trained Pathologists 78
Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies 78
MicroRNA expression profiling of Xp11 renal cell carcinoma 78
Concurrent targeting of potential cancer stem cells regulating pathways sensitizes lung adenocarcinoma to standard chemotherapy 78
The epidermal growth factor receptor is frequently overexpressed in penile squamous cell carcinomas: a tissue microarray and digital image analysis study of 112 cases 77
Characterization of human NK cell-derived exosomes: Role of DNAM1 receptor in exosome-mediated cytotoxicity against tumor 77
PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability 76
Artificial intelligence in head and neck cancer diagnosis 74
Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: a retrospective study of patients treated using radical cystectomy 74
Non-small cell lung cancer: land of conquest for immunotherapy 73
Human papillomavirus infection and immunohistochemical p16(INK4a) expression as predictors of outcome in penile squamous cell carcinomas 73
PD-L1 expression heterogeneity in non-small cell lung cancer: defining criteria for harmonization between biopsies and whole sections 72
Expression of programmed cell death ligand 1 in non-small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 Assay 72
TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine 71
Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes 71
Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua 71
Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification 69
Cathepsin k: A novel diagnostic and predictive biomarker for renal tumors 69
Strong association of insulin-like growth factor 1 receptor expression with histologic grade, subtype, and HPV status in penile squamous cell carcinomas: a tissue microarray study of 112 cases 68
Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes? 68
Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma 66
Overexpression of Insulin-like Growth Factor-1 Receptor Is Associated With Penile Cancer Progression 66
Impact of PD-L1 and PD-1 Expression on the Prognostic Significance of CD8+ Tumor-Infiltrating Lymphocytes in Non-Small Cell Lung Cancer 66
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation 65
TCL1A expression in marginal zone lymphoma: a clinico-pathological evaluation in paired spleen and bone marrow samples 65
Challenges facing pathologists evaluating PD-L1 in head & neck squamous cell carcinoma 64
Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems 62
Evaluation of S-phase fraction as a prognostic marker in mantle cell lymphoma 62
Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome 62
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma 59
Different effects of NK cells and NK-derived soluble factors on cell lines derived from primary or metastatic pancreatic cancers 58
PD-1/pd-l1 in cancer: Pathophysiological, diagnostic and therapeutic aspects 58
The immune checkpoint PD-1 in natural killer cells: Expression, function and targeting in tumour immunotherapy 58
Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD-1 receptor 58
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study 56
Predicting progression in T1 non-muscle-invasive bladder cancer: back to histology 55
Exploiting Human NK Cells in Tumor Therapy 55
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 53
NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines 53
Wilms’ tumor primary cells display potent immunoregulatory properties on nk cells and macrophages 52
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells 51
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 50
PD-L1 Expression in de Novo Metastatic Castration-sensitive Prostate Cancer 48
PD-L1 evaluation in head and neck squamous cell carcinoma: Insights regarding specimens, heterogeneity and therapy 48
Pediatric tumors-mediated inhibitory effect on nk cells: The case of neuroblastoma and Wilms’ tumors 46
Program death ligand-1 immunocytochemistry in lung cancer cytological samples: A systematic review 45
Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity 42
Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28 42
PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation 41
Technical and Diagnostic Issues in Whole Slide Imaging Published Validation Studies 39
Helper Innate Lymphoid Cells in Human Tumors: A Double-Edged Sword? 39
Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma 35
Histopathological evaluation and grading for prostate cancer: current issues and crucial aspects 18
Totale 6.835
Categoria #
all - tutte 51.763
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.763


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022345 0 0 11 41 4 7 9 56 84 29 34 70
2022/2023263 81 0 6 2 5 89 6 17 32 2 13 10
2023/2024539 17 14 12 96 14 70 11 27 181 2 4 91
2024/20251.240 4 9 11 118 127 84 132 31 163 175 244 142
2025/20262.805 227 421 305 532 182 90 301 113 250 225 120 39
2026/2027331 140 139 52 0 0 0 0 0 0 0 0 0
Totale 6.835